The Essentials of Building the Right Foundation

"I love to be involved in something that makes a change in someone's life. That's why, through our companies, we design products that make a positive impact. We're not just saving lives, we're helping people live better lives. That's what I enjoy the most," shares Abhita Batra. Her vision for Neuro42, where she is co-founder and CSO (chief strategy officer), is fusing MRI technology, artificial intelligence, and robotics. Occupying space in this interdisciplinary field positions Neuro42 as a pioneer.

Abhita's journey is paved with both academic rigor and real-world experience. Her impressive educational background, starting with a foundation in biotechnology and culminating in executive MBAs from top institutions, speaks volumes about her dedication to continuous learning and growth. She honed her skills in business development and strategic consulting in various firms like 8chili, Otomagnetics, Admac Oncology, and Navya Biomedical Technologies.

Her focus today is Neuro42, which has achieved significant milestones since its founding in 2020, including raising $18 million in funding. 

The origin of Neuro42 is a story of seizing opportunity and technological innovation, which began when the founding team licensed a novel technology from Massachusetts General Hospital. Today, it forms the basis of their intraoperative MRI system, capable of scanning patients for brain injuries during surgery. 

But Neuro42's ambition soars beyond scanning. They envision an even more transformative future, one where MRI seamlessly integrates with AI and robotics as demonstrated by their collaboration with Johns Hopkins.

Neuro42’s diagnostic technology is designed to be integrated in various settings, ranging from stroke and urgent care centers to office environments while their interventional product, on the other hand, is aimed for use in ICUs and operating rooms.

Neuro42 just received 510(k) clearance from FDA for its portable diagnostic MRI scanner. 

Key Learnings From Abhita’s Experience

• At the outset of your startup, your first two concerns should be building a knowledgeable and adaptable team and conducting a thorough market analysis to pinpoint the gap you aim to fill.

• When it comes to navigating the regulatory landscape, you should meticulously plan your path, realistically predict the corresponding timelines, and allow your team enough room to respond to FDA's requests while ensuring your course aligns with fundraising milestones. 

• Every stage of your company requires a different approach to fundraising. The amount you’re raising, the promises you’re making, and the proof you need to show all vary. But in essence, the key is to present a compelling case and communicate it clearly to potential investors and partners.